FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Energy Manager News
- Microgrids, Now Mainstream, Continue to Advance
- Developing Economies Increasing their Share of Renewable Capacity
- LG Chem In Big German Battery Project
- ERC: Electricity Price Trends for the Week Ending Nov. 20
- PUCO: ‘Fixed Means Fixed’ in Retail Contracts
- FERC Requires Reports on Price Formation
- Viridian Energy Moves into Texas Market
- PUC Approves PPL’s 6.1% Rate Hike